Your browser doesn't support javascript.
Presumed population immunity to SARS-CoV-2 in South Korea, April 2022.
Jang, Eun Jung; Choe, Young June; Choe, Seung Ah; Kim, Yoo-Yeon; Kim, Ryu Kyung; Kim, Jia; Lim, Do Sang; Lee, Ju Hee; Yi, Seonju; Lee, Sangwon; Park, Young-Joon.
  • Jang EJ; Korea Disease Control and Prevention Agency, Cheongju, Korea.
  • Choe YJ; Department of Pediatrics, Korea University Anam Hospital, Seoul, Korea.
  • Choe SA; Department of Preventive Medicine, Korea University College of Medicine, Seoul, Korea.
  • Kim YY; Korea Disease Control and Prevention Agency, Cheongju, Korea.
  • Kim RK; Korea Disease Control and Prevention Agency, Cheongju, Korea.
  • Kim J; Korea Disease Control and Prevention Agency, Cheongju, Korea.
  • Lim DS; Korea Disease Control and Prevention Agency, Cheongju, Korea.
  • Lee JH; Korea Disease Control and Prevention Agency, Cheongju, Korea.
  • Yi S; Korea Disease Control and Prevention Agency, Cheongju, Korea.
  • Lee S; Korea Disease Control and Prevention Agency, Cheongju, Korea.
  • Park YJ; Korea Disease Control and Prevention Agency, Cheongju, Korea.
Osong Public Health Res Perspect ; 13(5): 377-381, 2022 Oct.
Article in English | MEDLINE | ID: covidwho-2100733
ABSTRACT

OBJECTIVES:

We estimated the overall and age-specific percentages of the Korean population with presumed immunity against severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) as of April 2022 using the national registry.

METHODS:

We used the national coronavirus disease 2019 (COVID-19) infection and vaccination registry from South Korea, as described to define individuals with a previous history of COVID-19 infection, vaccination, or both, as persons with presumed immunity.

RESULTS:

Of a total of 53,304,627 observed persons, 24.4% had vaccination and infection, 58.1% had vaccination and no infection, 7.6% had infection and no vaccination, and 9.9% had no immunity. The SARS-CoV-2 Omicron variant emerged at a time when the presumed population immunity ranged from 80% to 85%; however, nearly half of the children were presumed to have no immunity.

CONCLUSION:

We report a gap in population immunity, with lower presumed protection in children than in adults. The approach presented in this work can provide valuable informed tools to assist vaccine policy-making at a national level.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Topics: Vaccines / Variants Language: English Journal: Osong Public Health Res Perspect Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Topics: Vaccines / Variants Language: English Journal: Osong Public Health Res Perspect Year: 2022 Document Type: Article